Masayo Shamoto‐Nagai

Mitochondrial Genome Variation in Eastern Asia and the Peopling of Japan

Masashi Tanaka, Vicente M. Cabrera, Ana González et al. · Genome Research · 2004 · 528 citations · Full text

Life Sciences, Biology, Genetics +17

Mitochondrial permeability transition mediates apoptosis induced by <i>N</i>‐methyl(<i>R</i>)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl‐2 and rasagiline, <i>N</i>‐propargyl‐1(<i>R</i>)‐aminoindan

Yukihiro Akao, Wakako Maruyama, Shigeomi Shimizu et al. · Journal of Neurochemistry · 2002 · 165 citations

Life Sciences, Neuroscience, Pharmacology +13

An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH‐SY5Y cells

Masayo Shamoto‐Nagai, Wakako Maruyama, Yoji Kato et al. · Journal of Neuroscience Research · 2003 · 142 citations

Life Sciences, Biochemistry, Neuroscience +17

An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic Bcl-2 in human dopaminergic SH-SY5Y cells

Yukihiro Akao, Wakako Maruyama, Hong Yi et al. · Neuroscience Letters · 2002 · 123 citations

Medicine, Neuroscience, Pharmacology +16

In parkinsonian substantia nigra, α-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity

Masayo Shamoto‐Nagai, W. Maruyama, Yoshio Hashizume et al. · Journal of Neural Transmission · 2007 · 115 citations

Life Sciences, Biochemistry, Neuroscience +17